247 related articles for article (PubMed ID: 36843552)
1. A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.
Zhu L; Tang Y; Li XY; Kerk SA; Lyssiotis CA; Feng W; Sun X; Hespe GE; Wang Z; Stemmler MP; Brabletz S; Brabletz T; Keller ET; Ma J; Cho JS; Yang J; Weiss SJ
EMBO J; 2023 Apr; 42(7):e111148. PubMed ID: 36843552
[TBL] [Abstract][Full Text] [Related]
2. Novel Insights into Osteoclast Energy Metabolism.
Ledesma-Colunga MG; Passin V; Lademann F; Hofbauer LC; Rauner M
Curr Osteoporos Rep; 2023 Dec; 21(6):660-669. PubMed ID: 37816910
[TBL] [Abstract][Full Text] [Related]
3. ZEB1 regulates bone metabolism in osteoporotic rats through inducing POLDIP2 transcription.
Zhu X; Yan F; Liu L; Huang Q
J Orthop Surg Res; 2022 Sep; 17(1):423. PubMed ID: 36123704
[TBL] [Abstract][Full Text] [Related]
4. G-protein Gα
Nakano S; Inoue K; Xu C; Deng Z; Syrovatkina V; Vitone G; Zhao L; Huang XY; Zhao B
Sci Rep; 2019 Mar; 9(1):4236. PubMed ID: 30862896
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
[TBL] [Abstract][Full Text] [Related]
6. Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton.
Das BK; Wang L; Fujiwara T; Zhou J; Aykin-Burns N; Krager KJ; Lan R; Mackintosh SG; Edmondson R; Jennings ML; Wang X; Feng JQ; Barrientos T; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
Elife; 2022 Jun; 11():. PubMed ID: 35758636
[TBL] [Abstract][Full Text] [Related]
7. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
[TBL] [Abstract][Full Text] [Related]
8. Increased bone resorption by osteoclast-specific deletion of the sodium/calcium exchanger isoform 1 (NCX1).
Albano G; Dolder S; Siegrist M; Mercier-Zuber A; Auberson M; Stoudmann C; Hofstetter W; Bonny O; Fuster DG
Pflugers Arch; 2017 Feb; 469(2):225-233. PubMed ID: 27942992
[TBL] [Abstract][Full Text] [Related]
9. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia.
Nakajima A; Sanjay A; Chiusaroli R; Adapala NS; Neff L; Itzsteink C; Horne WC; Baron R
J Bone Miner Res; 2009 Jul; 24(7):1162-72. PubMed ID: 19257814
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
[TBL] [Abstract][Full Text] [Related]
11. Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis
Wang L; Fang B; Fujiwara T; Krager K; Gorantla A; Li C; Feng JQ; Jennings ML; Zhou J; Aykin-Burns N; Zhao H
J Biol Chem; 2018 Jun; 293(24):9248-9264. PubMed ID: 29724825
[TBL] [Abstract][Full Text] [Related]
12. Runx1-mediated regulation of osteoclast differentiation and function.
Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
[TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of osteoclast activity.
Bruzzaniti A; Baron R
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):123-39. PubMed ID: 16951988
[TBL] [Abstract][Full Text] [Related]
14. Role of cell-matrix interactions in osteoclast differentiation.
McHugh KP; Shen Z; Crotti TN; Flannery MR; Fajardo R; Bierbaum BE; Goldring SR
Adv Exp Med Biol; 2007; 602():107-11. PubMed ID: 17966395
[TBL] [Abstract][Full Text] [Related]
15. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption.
Charles JF; Coury F; Sulyanto R; Sitara D; Wu J; Brady N; Tsang K; Sigrist K; Tollefsen DM; He L; Storm D; Aliprantis AO
Bone; 2012 Nov; 51(5):902-12. PubMed ID: 22985540
[TBL] [Abstract][Full Text] [Related]
16. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
[TBL] [Abstract][Full Text] [Related]
17. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.
Zhu L; Tang Y; Li XY; Kerk SA; Lyssiotis CA; Sun X; Wang Z; Cho JS; Ma J; Weiss SJ
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36880731
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast function and bone-resorbing activity: An overview.
Soysa NS; Alles N
Biochem Biophys Res Commun; 2016 Jul; 476(3):115-20. PubMed ID: 27157135
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Adseverin in Osteoclasts Affects Cell Structure But Not Bone Metabolism.
Cao Y; Wang Y; Sprangers S; Picavet DI; Glogauer M; McCulloch CA; Everts V
Calcif Tissue Int; 2017 Aug; 101(2):207-216. PubMed ID: 28389691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
